Wedbush: BioMarin Pharma Still Worth $104/Share
April 23, 2015 at 06:41 AM EDT
In a report published Thursday, Wedbush analysts maintained a Neutral rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.